Skip to main content
. 2018 May 7;2018:3061084. doi: 10.1155/2018/3061084

Table 4.

Long-term sequel according to diagnosis and treatment.

Diagnosis Treatment
SJS, N = 20 Overlap-TEN, N = 16 P value Supportive care, N = 8 Systemic treatment, N = 28 P value
Long-term skin sequel, N (%)
Dyspigmentation 4 (20.0) 14 (87.5) <0.001 3 (37.5) 15 (53.6) 0.423
 Xerosis 1 (5.0) 0 0.364 1 (12.5) 0 0.058
 Nail loss 0 1 (6.2) 0.257 0 1 (3.6) 0.588

Long-term eye sequel, N (%)
 Dry eye 4 (20.0) 6 (37.5) 0.244 4 (50.0) 6 (21.6) 0.112
 Corneal scar 0 4 (25.0) 0.018 1 (12.5) 3 (10.7) 0.887
 Keratopathy 0 3 (18.8) 0.043 2 (25.0) 1 (3.6) 0.053
 Subconjunctival fibrosis 0 1 (6.2) 0.257 0 1 (3.6) 0.588

Long-term GI sequel, N (%)
 Transaminitis
  Less than 3 m 2 (10.0) 5 (31.2) 0.109 2 (25.0) 5 (17.9) 0.653
  More than 3 m 0 1 (6.2) 0.257 0 1 (3.6) 0.588

Significant values are shown in bold.